Avalere Health

✨ Menopause can be an empowering stage of life but the transition can also be tough. As colleagues, managers, friends, and family members, we all need to be aware of the potential impact and ready to provide support – particularly at work. That’s why this #WorldMenopauseDay, we’ve partnered with menopause experts ZAOWOMAN, co-founded by our own Jocelyn Crouch, and created a global menopause policy, tools, and resources. Through shared understanding, knowledge, empathy and (most importantly) real action, we’re building a workplace that works for everyone. Learn more about our culture: https://bit.ly/4ojqZ8g

🔎 Looking for interesting reading ahead of #ESMO2025? Look no further. We’ve analyzed data across the solid tumor landscape in 2025, including the what to look out for at the ESMO - European Society for Medical Oncology congress. Download the report written by oncology expert Debra Scates, Unit Director of Scientific Services, Medical, i-ONE (International Oncology Network for Education). https://bit.ly/4n4NPQ9 #WeAreAvalereHealth #AvalereHealthMedical

📖 With the emergence of AI and a wealth of scientific breakthroughs, the blood cancer landscape is more complex than ever before. In our latest article, Anagha Shukla and Sonie Modino, two expert storytellers in our Global Marketing team, explain why a 360-degree approach to crafting compelling communications – encompassing insights from every facet of the hemato-oncology environment – is key for turning scientific breakthroughs into meaningful, real-world impact: https://bit.ly/46Tglzp #EveryPatientPossible #WeAreAvalereHealth #BloodCancer

📣 Are you attending ASSOCIATION FOR VALUE-BASED CANCER CARE 2025? We’re hosting 5 exciting panels on the latest trends in market access, providing insights and guidance on how to ensure life-changing cancer medicines reach every patient possible.   We’re committed to ensuring no patient with cancer is left behind. Meet our Advisory team, including Sarah Alwardt; Kolton Gustafson, MPH; Maddi Davidson; Mina Alsaraf Allo; and Brian Gillespie, at #AVBCC2025. Learn how our policy, value, evidence, and access teams ensure oncology products reach every eligible patient. https://bit.ly/4noaQxH

🚨 Hot off the press, the latest edition of #PolicyToPatient covers major moves from the Trump administration to reduce drug prices, including the launch of TrumpRx – a new DTC channel. So, what do the changes mean for Medical and Marketing teams? Get up to speed on: 💊The impact in the context of the wider pressures on biopharmaceutical manufacturers 💊TrumpRx and the latest deals inked with manufacturers 💊The opportunity for a bespoke DTC landscape analysis for your brands.

"I'm excited about how AI could help us to tackle inequalities in healthcare: in clinical trials, in location, in access... by standardizing those variables, we can get to a world where no patient is left behind."   Our CEO Amar Urhekar sat down with Harshit Jain of #TheNextMarketingWithHJ for a wide-ranging discussion on AI and the future of healthcare, covering timely topics including:   ✅ How AI can be boost the powers of radical empathy and predictability in healthcare to make impact for every patient ✅ The ways in which Avalere Health is using AI for both daily efficiency and innovative projects to enable better outcomes for stakeholders ✅ Finding the optimal balance of speed, caution, and risk when managing AI projects involving patients and their care   Listen to the full conversation now: https://bit.ly/42VMm7B   #AI #AIinHealthcare

🧬 Our 500+ oncology specialists in Advisory, Medical, and Marketing fuse deep scientific knowledge with radical empathy, ensuring ground-breaking treatments reach every patient, everywhere. Want to learn more? Meet us at #ESMO2025 or book a virtual meeting https://bit.ly/4gZsyWu   #EveryPatientPossible #WeAreAvalereHealth #Oncology 

🔬 With #ESMO2025 around the corner, our #oncology specialists are excited to continue enhancing their knowledge of emerging innovations. In this video, Ryan Bourgo, Scientific Director in our Medical team, shares his analysis of one of the top trends to watch in the oncology space – the combination of multiple agents to prevent cancer cells from evading treatment. Are you attending ESMO? Book a meeting with our Advisory, Medical, and Marketing teams to learn how we can help ensure your oncology products and services reach every patient. Not attending ESMO? Get in touch to learn how we can solve your challenges https://bit.ly/48n4law

🧬 There’s no other therapy area like #oncology. From the uniqueness of tumor types to the speed of innovation and the ability to make a profound difference to people’s lives. It’s that wonderful complexity that makes our oncology specialists excited to go to work every day and energized for #ESMO2025. Are you attending this year's ESMO - European Society for Medical Oncology congress? Book a meeting with our Advisory, Medical, and Marketing teams to learn how we can support you to reach every patient https://bit.ly/46V0hM4

👩⚕️ Did you know that we have incredible i-ONE (International Oncology Network for Education) partnerships with top global opinion leaders in lung, breast, prostate, and bladder cancer? Contact [email protected] to learn about our oncology conference analysis programs, including the landmark bladder cancer meeting at #ESMO2025 and the November 3rd panel chaired by leading bladder cancer expert Prof. Dr. Axel S. Merseburger.